In first look at mR­NA pro­tein re­place­ment, Mod­er­na touts ear­ly sig­nals of promise for rare meta­bol­ic ther­a­py

LOS AN­GE­LES — Mod­er­na pre­sent­ed ear­ly da­ta on its mR­NA treat­ment for pro­pi­onic acidemia (PA), a rare meta­bol­ic dis­ease where peo­ple can’t break down cer­tain …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER